47 studies found for:    " May 25, 2011":" June 24, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" May 25, 2011":" June 24, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Safety and Tolerability of Crofelemer for HIV-Associated Diarrhea
Conditions: HIV Enteropathy;   Diarrhea With HIV
Intervention: Drug: Crofelemer
2 Active, not recruiting A Clinical Trial Comparing the Efficacy of Darunavir/Ritonavir Monotherapy Versus a Triple Combination Therapy Containing Darunavir/Ritonavir and 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Patients With Undetectable Plasma HIV-1 RNA on Current Treatment
Conditions: Human Immunodeficiency Virus (HIV) Infections;   Acquired Immunodeficiency Syndrome (AIDS) Virus
Interventions: Drug: Darunavir;   Drug: Ritonavir
3 Active, not recruiting Feasibility of a Stigma Reduction Intervention for Human Immunodeficiency Virus (HIV)-Infected Women
Conditions: Human Immunodeficiency Virus (HIV);   Self-efficacy;   Self-esteem
Intervention: Behavioral: Ipod video
4 Recruiting HIV, Buprenorphine, and the Criminal Justice System
Conditions: Human Immunodeficiency Virus;   Acquired Immunodeficiency Syndrome;   Opiate Addiction;   Drug Dependence
Intervention: Drug: Buprenorphine/naloxone
5 Completed HIV Diagnosis in Hospitalized Malawian Infants
Condition: HIV Infections
Intervention: Device: Point of care HIV RNA PCR
6 Completed Safety and Pharmacokinetics of Dapivirine/Maraviroc Vaginal Ring
Condition: HIV Infections
Interventions: Drug: Dapivirine Vaginal Ring;   Drug: Maraviroc Vaginal Ring;   Other: Placebo Vaginal Ring;   Drug: Dapivirine-Maraviroc Vaginal Ring
7 Completed HAART Adherence Among HIV-infected Persons and the Factors Affecting Treatment Adherence
Conditions: Acute HIV Infection;   Acquired Immunodeficiency Syndrome;   Medication Adherence
Intervention: Behavioral: Advanced Adherence Counseling (AdvAdh)
8 Recruiting Switch to Darunavir/r + Maraviroc Quaque Die in Patients With R5 Tropism by Viral DNA Genotyping (GUSTA)
Condition: HIV Infection
Interventions: Drug: Maraviroc, Darunavir/r;   Drug: current antiretroviral therapy with 3 drugs
9 Completed A Phase IIA Trial to Evaluate the Safety and Immunogenicity of a DNA HIV-1 Vaccine Followed by an MVA HIV-1 Vaccine in HIV-uninfected Volunteers
Condition: HIV Infections
Interventions: Biological: DNA.HIVA;   Biological: MVA.HIVA
10 Completed Non-interventional Study on Use of Darunavir With Ritonavir in Clinical Practice
Condition: HIV Infections
Intervention: Drug: darunavir/ritonavir plus background regimen
11 Recruiting A Self-Assessment Intervention for Young Adult Polydrug Users at Risk for HIV
Conditions: HIV Infection;   Substance Abuse
Interventions: Behavioral: Trans-theoretical Process of Change Model-self;   Behavioral: Trans-theoretical Process of Change Model - interviewer
12 Active, not recruiting Safety and Effect on HIV Transcription of Vorinostat in Patients Receiving Suppressive Combination Anti-retroviral Therapy
Condition: HIV Positive
Intervention: Drug: Vorinostat
13 Active, not recruiting Safety of and Immune Response to a DNA HIV Vaccine Boosted With a Modified Vaccinia HIV Vaccine and Protein HIV Vaccine in Healthy Adults
Conditions: HIV Seronegativity;   HIV Preventive Vaccine
Interventions: Biological: MVA-C + gp140/MF59;   Biological: DNA-C2 + MVA-C;   Biological: DNA-C2 + MVA-C + gp140/MF59
14 Completed
Has Results
A Study to Compare Brachial Artery Reactivity and Cardiovascular Risk of a Treatment Simplification by Darunavir/Ritonavir (DRV/r) 800/100 mg Versus a Triple Combination Therapy Containing DRV/r in HIV-1 Infected Patients
Condition: Human Immunodeficiency Virus 1
Interventions: Drug: Darunavir(DRV);   Drug: Ritonavir;   Drug: 2 nucleoside reverse transcriptase inhibitors (NRTIs)
15 Completed Relative Bioavailability Study of a Pediatric Granule Formulation of Dolutegravir
Condition: Infections, Human Immunodeficiency Virus and Herpesviridae
Interventions: Drug: Dolutegravir 50 mg tablet;   Drug: Dolutegravir 50 mg oral granules
16 Completed Effect of Multiple Dosing With BI 201335 on the Pharmacokinetics of Darunavir Co-administered With Ritonavir in Healthy Male and Female Volunteers
Condition: HIV Infections
Interventions: Drug: Darunavir;   Drug: Ritonavir;   Drug: BI 201335
17 Completed Therapy to Elevate CD4 Counts in HIV-1 Disease
Condition: HIV Disease
Intervention: Biological: alpha-1-Proteinase Inhibitor
18 Active, not recruiting Evaluating the Safety and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults Who Have Participated in Previous HIV Vaccine Clinical Trials and in Adults Who Have Not Participated in Previous HIV Vaccine Clinical Trials
Condition: HIV Infections
Interventions: Biological: Sub C gp140 Vaccine;   Biological: MF59C.1 Adjuvant
19 Recruiting REMEMBER: Reducing Early Mortality & Morbidity by Empiric Tuberculosis (TB) Treatment
Condition: HIV Infection
Interventions: Drug: Atripla (r);   Drug: Efavirenz;   Drug: Truvada;   Drug: Rifampin/isoniazid/pyrazinamide/ethambutol FDC;   Drug: Rifampin/isoniazid FDC
20 Completed Relative Bioavailability Study of Two New Dolutegravir/Abacavir/Lamivudine Fixed Dose Combination Tablets
Conditions: Healthy Subjects;   Infection, Human Immunodeficiency Virus
Interventions: Drug: Dolutegravir 50 mg/abacavir 600 mg/lamivudine 300 mg;   Drug: Dolutegravir 50 mg;   Drug: abacavir 600 mg/lamivudine 300 mg

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years